TXRH:NASDAQTexas Roadhouse, Inc. Analysis
Data as of 2026-08-31 - not real-time
$195.60
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $195.60, Texas Roadhouse, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Relative strength is 39.9 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at $195.60 and resistance at $216.30.
The shares look overvalued at 31.3 times earnings, though no sector average was available for comparison. Consensus targets land 11.3% above where the shares trade now. Revenue is growing at 11.1% on a 6.6% profit margin. The 1.50% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 24.5%, a beta of 0.27 and a maximum drawdown of 20.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
The shares look overvalued at 31.3 times earnings, though no sector average was available for comparison. Consensus targets land 11.3% above where the shares trade now. Revenue is growing at 11.1% on a 6.6% profit margin. The 1.50% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 24.5%, a beta of 0.27 and a maximum drawdown of 20.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
In its recent update, Texas Roadhouse, Inc.Texas Roadhouse TXRH delivered earnings and revenue surprises of -2.Restaurant company Texas Roadhouse NASDAQ:TXRH in Q2 CY2026, with sales up 11.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 179.33
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 179.33
- Analyst targets imply +11.3% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +11.3% versus the current price
- Revenue growth of +11.1%
- P/E ratio of 31.3
Key Metrics & Analysis
Financial Health
Revenue Growth11.10%
Profit Margin6.63%
P/E Ratio31.3
ROE27.71%
ROA8.72%
Debt/Equity68.84
P/B Ratio8.4
Op. Cash Flow$803.3M
Free Cash Flow$235.9M
Technical Analysis
TrendBullish
RSI39.9
Support$195.60
Resistance$216.30
MA 20$205.11
MA 50$198.22
MA 200$179.33
MACDBearish
VolumeDecreasing
Fear & Greed Index94.36
Valuation
Fair Value$60.01
Target Price$217.74
Upside/Downside11.32%
GradeOvervalued
TypeGrowth
Dividend Yield1.50%
Risk Assessment
Beta0.27
Volatility24.50%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.